A growing body of research reveals alarming connections between chronic glucose spikes and neurodegenerative diseases like Alzheimer's, suggesting it shares traits with type two diabetes. Insulin resistance, mitochondrial dysfunction, and inflammation in the brain are key factors, raising concerns about the potential for early-onset dementia as metabolic health declines. The shift in understanding positions Alzheimer's as a metabolic disease rather than solely a plaque-based one, challenging long-held beliefs about its onset.
